These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis. Pathengay A; Shah GY; Das T; Sharma S Am J Ophthalmol; 2006 May; 141(5):938-40. PubMed ID: 16678510 [TBL] [Abstract][Full Text] [Related]
50. Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: a pilot study. Palakurthi NK; Correa ZM; Augsburger JJ; Banerjee RK J Ocul Pharmacol Ther; 2011 Apr; 27(2):151-6. PubMed ID: 21323470 [TBL] [Abstract][Full Text] [Related]
51. In situ ophthalmic gel of ciprofloxacin hydrochloride for once a day sustained delivery. Jain SP; Shah SP; Rajadhyaksha NS; Singh P S PP; Amin PD Drug Dev Ind Pharm; 2008 Apr; 34(4):445-52. PubMed ID: 18401787 [TBL] [Abstract][Full Text] [Related]
52. Vitreous and aqueous penetration of intravitreally and orally administered moxifloxacin in an experimental rabbit model of fungal endophthalmitis. Arikan S; Ozdek S; Aktas Z; Dinçel A; Hasanreisoglu B J Pharm Pharmacol; 2013 May; 65(5):659-64. PubMed ID: 23600382 [TBL] [Abstract][Full Text] [Related]
53. Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma. Kim J; Kudisch M; Mudumba S; Asada H; Aya-Shibuya E; Bhisitkul RB; Desai TA Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4341-6. PubMed ID: 27556217 [TBL] [Abstract][Full Text] [Related]
54. Intravitreal erythromycin in the treatment of induced staphylococcal endophthalmitis. Meisels HI; Peyman GA Ann Ophthalmol; 1976 Aug; 8(8):939-43. PubMed ID: 1085597 [TBL] [Abstract][Full Text] [Related]
55. Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy. Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y Curr Eye Res; 1995 Jun; 14(6):473-7. PubMed ID: 7671629 [TBL] [Abstract][Full Text] [Related]
56. Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis. De Kaspar HM; Ta CN; Engelbert M; Mette M; Thiel M; Kampik A Retina; 2008 Feb; 28(2):326-32. PubMed ID: 18301039 [TBL] [Abstract][Full Text] [Related]
57. Comparison of aqueous humour and vitreous humour levels of two 0.3% ciprofloxacin eyedrops. Cekiç O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO Can J Ophthalmol; 1998 Dec; 33(7):373-6. PubMed ID: 9885752 [TBL] [Abstract][Full Text] [Related]
58. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment. Bucher RS; Hall E; Reed DM; Richards JE; Johnson MW; Zacks DN Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284 [TBL] [Abstract][Full Text] [Related]
59. Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration. Cekiç O; Batman C; Yasar U; Başci NE; Bozkurt A; Kayaalp SO Eye (Lond); 1999 Aug; 13 ( Pt 4)():555-8. PubMed ID: 10692930 [TBL] [Abstract][Full Text] [Related]
60. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone. Small KW; Chan CK; Silva-Garcia R; Walsh TJ Ophthalmology; 2014 Apr; 121(4):952-8. PubMed ID: 24507858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]